{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:03:19Z","timestamp":1768078999433,"version":"3.49.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/mca.0000000000000255","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T13:32:38Z","timestamp":1430919158000},"page":"409-421","source":"Crossref","is-referenced-by-count":74,"title":["NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins"],"prefix":"10.1097","volume":"26","author":[{"given":"Afrasyab","family":"Altaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayuan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210204","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/01.CIR.0000017860.20619.23","article-title":"In vivo imaging of proteolytic activity in atherosclerosis.","volume":"105","author":"Chen","year":"2002","journal-title":"Circulation"},{"key":"R2-8-20210204","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/clinchem\/45.11.1967","article-title":"Inflammatory markers in men with angiographically documented coronary heart disease.","volume":"45","author":"Rifai","year":"1999","journal-title":"Clin Chem"},{"key":"R3-8-20210204","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2796.2000.00654.x","article-title":"Changing concepts of atherogenesis.","volume":"247","author":"Libby","year":"2000","journal-title":"J Intern Med"},{"key":"R4-8-20210204","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0021-9150(84)90127-8","article-title":"Monocytic origin of foam cells in human atherosclerotic plaques.","volume":"53","author":"Aqel","year":"1984","journal-title":"Atherosclerosis"},{"key":"R5-8-20210204","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0021-9150(87)90273-5","article-title":"Development of intracellular lipid deposits in the lipid-laden cells of atherosclerotic lesions. A cytochemical and ultrastructural study.","volume":"67","author":"Lupu","year":"1987","journal-title":"Atherosclerosis"},{"key":"R6-8-20210204","first-page":"253","article-title":"Early atherogenesis in the white carneau pigeon, 111. Lipid accumulation in nascent foam cells.","volume":"128","author":"Jerome","year":"1987","journal-title":"Am J Pathol"},{"key":"R7-8-20210204","first-page":"263","article-title":"The fine structure of human atherosclerotic lesions.","volume":"38","author":"Geer","year":"1961","journal-title":"Am J Pathol"},{"key":"R8-8-20210204","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":". Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R9-8-20210204","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.ATV.16.8.1000","article-title":"Interleukin-1 beta in coronary arteries of patients with ischemic heart disease.","volume":"16","author":"Galea","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R10-8-20210204","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.","volume":"5","author":"Rajamaki","year":"2010","journal-title":"PLoS One"},{"key":"R11-8-20210204","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000315469","article-title":"New insights into the regulation of signalling by TOLL-like receptors and NOD-like receptors.","volume":"2","author":"Rebecca","year":"2010","journal-title":"J Innate Immun"},{"key":"R12-8-20210204","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":". Cutting edge: NF-B activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J Immunol"},{"key":"R13-8-20210204","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4049\/jimmunol.0900173","article-title":"Cutting edge: TNF- mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation.","volume":"183","author":"Franchi","year":"2009","journal-title":"J Immunol"},{"key":"R14-8-20210204","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/HYPERTENSIONAHA.111.180935","article-title":"Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications.","volume":"58","author":"Xian","year":"2011","journal-title":"Hypertension"},{"key":"R15-8-20210204","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.smim.2009.05.002","article-title":"The NLRP3 inflammasome: a sensor of immune danger signals.","volume":"21","author":"Cassel","year":"2009","journal-title":"Semin Immunol"},{"key":"R16-8-20210204","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/ATVBAHA.106.129957","article-title":". Apolipoprotein E interrupts interleukin-1 signaling in vascular smooth muscle cells.","volume":"27","author":"Kawamura","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R17-8-20210204","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","article-title":"AtheroGene Investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina.","volume":"106","author":"Blankenberg","year":"2002","journal-title":"Circulation"},{"key":"R18-8-20210204","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins.","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"R19-8-20210204","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacc.2007.04.050","article-title":". Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure.","volume":"50","author":"Zaca","year":"2007","journal-title":"JACC"},{"key":"R20-8-20210204","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis.","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"R21-8-20210204","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3892\/ijmm.2012.1026","article-title":"Role of NLRP3 and CARD8 in the regulation of TNF- induced IL-1 release in vascular smooth muscle cells.","volume":"30","author":"Tangi","year":"2012","journal-title":"Int J Mol Med"},{"key":"R22-8-20210204","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.0000037106.76139.53","article-title":"ACCAHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction-2002: summary article: a report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina).","volume":"106","author":"Braunwald","year":"2002","journal-title":"Circulation"},{"key":"R23-8-20210204","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":". Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology.","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"key":"R24-8-20210204","first-page":"105","article-title":"Isolation and culture of human macrophages.","volume":"290","author":"Davies","year":"2005","journal-title":"Methods Mol Biol"},{"key":"R26-8-20210204","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/01.CIR.89.5.2462","article-title":". A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.","volume":"89","author":"Stary","year":"1994","journal-title":"Circulation"},{"key":"R27-8-20210204","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbrc.2012.07.011","article-title":"Oxidized low-density lipoprotein induces secretion of interleukin-1 by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation.","volume":"425","author":"Jiang","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R28-8-20210204","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1189\/jlb.0309164","article-title":"Cholesterol-dependent cytolysins induce rapid release of mature IL-1 from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner.","volume":"86","author":"Chu","year":"2009","journal-title":"J Leukoc Biol"},{"key":"R29-8-20210204","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)80943-5","article-title":"Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE.","volume":"92","author":"Wang","year":"1998","journal-title":"Cell"},{"key":"R30-8-20210204","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome. A molecular platform triggering activation of inflammatory caspases and processing of proIL-1.","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"R31-8-20210204","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0014-5793(98)01275-7","article-title":". Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity.","volume":"438","author":"Vancompernolle","year":"1998","journal-title":"FEBS Lett"},{"key":"R32-8-20210204","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/bbrc.1998.9425","article-title":". Cathepsin B-mediated activation of the proinflammatory caspase-11.","volume":"251","author":"Schotte","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R33-8-20210204","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.110.207415","article-title":"Recent advances on the role of cytokines in atherosclerosis.","volume":"31","author":"Ait-Oufella","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R34-8-20210204","doi-asserted-by":"crossref","first-page":"843","DOI":"10.5114\/aoms.2010.19289","article-title":"Effect of repeated ischaemic preconditioning on TLR4 and proinflammatory cytokines TNF- and IL-1 in myocardial ischaemia-reperfusion injury in a rat model.","volume":"6","author":"Ma","year":"2010","journal-title":"Arch Med Sci"},{"key":"R35-8-20210204","first-page":"36","article-title":"Apolipoprotein E knockout mice: an experimental model to study inflammatory mechanisms of atherosclerosis and to screen a putative anti-atherogenic properties of drugs.","volume":"37","author":"Jacek","year":"2012","journal-title":"Cent Eur J Immunol"},{"key":"R36-8-20210204","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/heart.88.5.467","article-title":". Increased plasma concentrations of interleukin-18 in acute coronary syndromes.","volume":"88","author":"Mallat","year":"2002","journal-title":"Heart"},{"key":"R37-8-20210204","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0038-1657525","article-title":"Oxidized lipids in atherogenesis: formation, destruction and action.","volume":"78","author":"Berliner","year":"1997","journal-title":"Thromb Haemost"},{"key":"R38-8-20210204","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbrc.2012.07.011","article-title":". Oxidized low- density lipoprotein induces secretion of interleukin-1 by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation.","volume":"425","author":"Jiang","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R39-8-20210204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00011-013-0667-3","article-title":"Ox-LDL-induced IL-1beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation.","volume":"63","author":"Weiwei","year":"2014","journal-title":"Inflamm Res"},{"key":"R40-8-20210204","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis.","volume":"91","author":"Hansson","year":"2002","journal-title":"Circ Res"},{"key":"R41-8-20210204","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/01.CIR.0000017860.20619.23","article-title":". In vivo imaging of proteolytic activity in atherosclerosis.","volume":"105","author":"Chen","year":"2002","journal-title":"Circulation"},{"key":"R42-8-20210204","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev.physiol.59.1.63","article-title":"Emerging roles for cysteine proteases in human biology.","volume":"59","author":"Chapman","year":"1997","journal-title":"Annu Rev Physiol"},{"key":"R43-8-20210204","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/ATVBAHA.109.194613","article-title":". Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging.","volume":"30","author":"Dong","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R44-8-20210204","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":". The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.","volume":"7","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"key":"R45-8-20210204","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":". NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"R46-8-20210204","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":". Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemiareperfusion injury.","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"R47-8-20210204","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality in acute coronary syndromes. A TIMI 11A substudy.","volume":"31","author":"Morrow","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R48-8-20210204","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.0000015464.18023.0A","article-title":". Approach to risk stratification in non-ST elevation acute coronary syndromes simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.","volume":"105","author":"Marc","year":"2002","journal-title":"Circulation"},{"key":"R49-8-20210204","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/CS20130043","article-title":"NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.","volume":"126","author":"Satoh","year":"2014","journal-title":"Clin Sci"},{"key":"R50-8-20210204","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/clc.4960280206","article-title":"Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting.","volume":"28","author":"Doo","year":"2005","journal-title":"Clin Cardiol"},{"key":"R51-8-20210204","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/hc2401.092816","article-title":"Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.","volume":"103","author":"Vasa","year":"2001","journal-title":"Circulation"},{"key":"R52-8-20210204","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1745-6215-7-35","article-title":". Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia - Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR).","volume":"7","author":"Clearfield","year":"2006","journal-title":"Trials"},{"key":"R53-8-20210204","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archinte.160.4.459","article-title":"The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.","volume":"160","author":"Pearson","year":"2000","journal-title":"Arch Intern Med"},{"key":"R54-8-20210204","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"R55-8-20210204","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9149(02)02443-8","article-title":". Short-term effect of atorvastatin (80 mg) on plasma lipids of patients with unstable angina pectoris or non-Q wave acute myocardial infarction.","volume":"90","author":"Correia","year":"2002","journal-title":"Am J Cardiol"},{"key":"R56-8-20210204","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0002-9149(03)00630-1","article-title":". Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction.","volume":"92","author":"Correia","year":"2003","journal-title":"Am J Cardiol"},{"key":"R57-8-20210204","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/hrt.2004.057489","article-title":". Effects of simvastatin within two weeks on anti-inflammatory cytokines interleukin 10 in patients with unstable angina.","volume":"92","author":"Li","year":"2006","journal-title":"Heart"},{"key":"R58-8-20210204","first-page":"17","article-title":"A review of the pharmacology and clinical effectiveness in cardiovascular diseases.","volume":"6","author":"Ahai","year":"2012","journal-title":"Clin Med Insights Cardiol"},{"key":"R59-8-20210204","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/ATVBAHA.110.218685","article-title":". Timing and sose of statin therapy define its impact on inflammatory and endothelial responses during myocardial infarction.","volume":"31","author":"Sposito","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:39:34Z","timestamp":1620959974000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019501-201508000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000255","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}